Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06484829 · RECRUITING
Trial details
- NCT number
- NCT06484829
- Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2026-02-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.